Low molecular weight heparin in prevention of perioperative thrombosis

British Medical Journal

Volumn 305, Issue 6859, 1992, Pages 913-920

  Leizorovicz, A ^a   Haugh, M C ^a   Chapuis, F R ^a   Samama, M M ^a   Boissel, J P ^a  

^a Service de Pharmacologie Clinique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENERAL SURGERY; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORTALITY; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOSIS;

EID: 0026761832     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.305.6859.913     Document Type: Article

References (72)

1. Dalen, J.E.; Paraskos, J.A.; Ockene, I.S.; Alpert, I.S.; Hirsh, J. Venous thromboembolism: scope of the problem Chest 1986 89 370
2. Hull, R.D.; Raskob, G.E.; Hirsh, J. Prophylaxis of venous thromboembolism: an overview Chest 1986 89 374
3. Kakkar, VV Prevention of venous thromboembolism Clinical Haematology 1981 10.1016/S0308-2261(21)00237-X 10 543
4. Collins, R.; Scrimgeour, A.; Yusuf, S.; Peto, R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic and urologic surgery N EnglJ7 Med 1988 10.1056/NEJM198805053181805 318 1162
5. Bergqvist, D. Dextran in the prophylaxis of deep-vein thrombosis JAMA 1987 10.1001/jama.1987.03400030040019 258 324
6. Hirsh, J. From unfractionated heparins to low molecular weight heparins Acta ChirScand 1990 556 42
7. Carter, C.J.; Kelton, J.G.; Hirsh, J.; Cerskus, A.; Santos, A.V.; Gent, M. The relationship between the haemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits Blood 1982 10.1182/blood.V59.6.1239.1239 59 1239
8. Cade, J.F.; Buchanan, M.R.; Boneu, B.; Ockelford, P.; Carter, C.J.; Cekus, A.L. A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions. 7hromb Res 1984 35 613
9. Buchanan, M.R.; Boneu, B.; Ofosu, F.A.; Hirsh, J. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin Blood 1985 10.1182/blood.V65.1.198.198 65 198
10. Esquivel, C.O.; Bergqvist, D.; Bjork, C.G.; Nilsson, B. Comparison between commercial heparin, low molecular weight heparin and pentosan polysulfate on haemostasis and platelets in vivo Thromb Res 1982 10.1016/0049-3848(82)90120-7 28 389
11. Lane, D.A.; Denton, J.; Flynn, A.M.; Thunberg, L.; Lindahl, U. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4 BiochemJ 1984 10.1042/bj2180725 218 725
12. Lockner, D.; Bratt, G.; Tornebohm, E.; Aberg, W. Pharmacokinetics of intravenously and subcutaneously administered fragmin in healthy volunteers Haemostasis 1986 16 8
13. Frydman, A.M.; Bara, L.; Le Roux, Y.; Woler, M.; Chauliac, F.; Samama, M. The antithrombotic activity and pharmacokinetics ofenoxaparin, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg J Clin Pharmacol 1988 10.1002/j.1552-4604.1988.tb03184.x 28 609
14. Boissel, J.P.; Bossard, N. Registry of multicenter clinical trials: eleventh report1989 Thromb Haemost 1991 10.1055/s-0038-1646422 66 368
15. Boissel, J.P.; Sacks, H.S.; Leizorovicz, A.; Blanchard, J.; Panak, E.; Peyrieux, J.C. Meta-analysis of clinical trials: summary of an international conference Eur J Clin Pharmacol 1988 10.1007/BF00615213 34 535
16. Thompson, S.G.; Pocock, S.J. Can meta-analyses be trusted? Lancet 1991 10.1016/0140-6736(91)91975-Z 338 1127
17. Fleiss, J. Statistical methods fcr rates and proportions 1973
18. Ockelford, P.A.; Patterson, J.; Johns, A.S. A double-blind randomized placebo controlled trial of thromboprophylaxis in major elective general surgery using once daily injections of a low molecular weight heparin fragment (Fragmin) Thromb Haemost 1989 10.1055/s-0038-1647114 62 1046
19. Pezzuoli, G.; Neri Serneri, G.G.; Settembrini, P.; Coggi, G.; Olivari, N.; Buzzetti, G. es al. Prevention de l'embolie pulmonaire mortelle en chirurgie generale par le CY 216, heparine de bas poids moleculaire: essai multicentrique, randomise, en double insu, controle contre placebo (Etude STEP) Int Surg 1989 74 205
20. Valle, I.; Sola, G.; Origone, A. Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent postoperative deep venous thrombosis Curr Med Res Opin 1988 10.1185/03007998809110450 11 80
21. Turpie, A.G.G.; Levine, M.N.; Hirsh, J.; Carter, C.J.; Jay, R.M.; Powers, J. A randomized controlled trial of low molecular weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery N EnglJ Med 1986 10.1056/NEJM198610093151503 315 925
22. Leclerc, J.; Geerts, W.; Desiardins, L.; Jobin, F.; Delorme, P.; Bourgouin, J. A randomized trial of enoxaparin for the prevention of deep vein thrombosis after major knee surgery Thromb Haemost 1991 65 753
23. Jorgensen, P.S.; Torholm, C.; Knudsen, J.B.; Boeng, L.; Josefson, L.; Bjerregaard, P. Thromboprophylactic effect oflow molecular weight heparin (Fragmin) in acute hip fracture surgery. A placebo controlled study Thromb Haemost 1989 62 525
24. Torholm, C.; Broeng, L.; Seest Jorgensen, P.; Bjerregaard, P.; Josephsen, L.; Korsholm Jorgensen, P. Thromboprophylaxis by low-molecularweight heparin in elective hip surgery J Bone joint Surg [Br] 1991 73 434
25. Lassen, M.L.; Borris, L.C.; Christiansen, H.M.; Olsen, A.D.; Schott, P.; Eiskjaer, S. Low molecular weight heparin in the prevention of thromboembolism in elective total hip replacement Throm Haemost 1989 62 126
26. Samama, M.; Bernard, P.; Bonnardot, J.P.; Combe-Tamzali, S.; Lanson, Y.; E, Tissot; G.E.N.O.X. Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis Br J Surg 1988 10.1002/bjs.1800750213 75 128
27. Veradi, S.; Casciani, C.U.; Nicora, E.; Forzano, F.; Origone, A.; Valle, I. A multicentre study of LMW-heparin effectiveness in preventing postsurgical thrombosis Int Angiol 1988 7 19
28. Bergqvist, D.; Burmark, U.S.; Frisell, J.; Hallbook, T.; Lindblad, B.; Risberg, B. Low molecular weight heparin once daily compared with conventional lowdose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis BrJ7 Surg 1986 73 204
29. MN1, Koller; U, Schoch; P, Buchmann; F, Largiader; von Felten A; PG, Frick Low molecular weight heparin (KABI 2165) as thromboprophylaxis in electivle visceral surgery. 7'hromb Haemost 1986 56 243
30. Onarheim, H.; Lund, T.; Heimdal, A.; Arnesio, B. A low molecular weight heparin (Kabi 2165) for prophvlaxis of postoperative deep venous thrombosis Acta ChirScand 1986 152 593
31. Borstad, E.; Urdal, K.; Handeland, G.; Abildgaard, U. Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery Acta Obstet Gynecol Scand 1988 10.3109/00016348809004178 67 99
32. Briel, R.C.; Doller, C.; Hermann, P. rhromboembolie-prophvlaxe bei hysterektomien mit dem niedermolekularen heparin Fragmin. Geburtsch u Frauenheilk 1988 48 160
33. Caen, J.P. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery Thromb Haemost 1988 10.1055/s-0038-1642757 59 216
34. Fricker, J.P.; Vergnes, Y.; Schach, R. Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin') in the prophylaxis of thromboembolic complications of abdominal oncological surgery Eurj C'lin Invest 1988 10.1111/j.1365-2362.1988.tb01268.x 18 561
35. Hartl, P.; Briicke, P.; Dienstl, E.; Vinazzer, H. Prophylaxis of thromboembolism in general surgery: comparison between standard heparin and fragmin Thromb Res 1990 10.1016/0049-3848(90)90074-M 57 577
36. Kakkar, VV, Murray W.X.'J.G. Efficacy and safety of low-molecular weight heparin (CY216) in preventing postoperative senous thrombo-embolism: a cooperative study Br] Surg 1985 10.1002/bjs.1800721006 72 786
37. Dahan, M\\,; P, Levasseur; J, Bogatv; B, Boneu; M, Samama Prevention of postoperative deep vein thrombosis (DVT) in malignant patients by Fraxiparin (a low molecular weight heparin). A cooperative trial. Thromb Haemost 1989; 62: 5 19
38. Leizorovicz, A.; Picolet, H.; Pevrieux, J.C.; Boissel, J.P.; the HBPM Research Group Prevention of perioperatis-e deep vein thrombosis in general surgery: a multicentre double blind study comparing two doses of Logiparin and standard heparin Br] Surg 1991 10.1002/bjs.1800780410 78 412
39. Schmitz-Huebner, U.; Bunte, H.; Freise, G.; Reers, B.; Ruschemever, C.; Scherer, R. Clinical efficacy of low molecular weight heparin in postoperatise thrombosis prophylaxis Klin Wochenschr 1984 10.1007/BF01716253 62 349
40. Adolf, J.; Knee, H.; Roder, J.D.; san de Flierdt, E.; Siewert, JR Thromboembolieprophvlaxe mit niedermolekularem Heparin in der Abdominalchirurgie Dtsch Med Wochenschr 1984 114 48
41. Heilmann, L.; Kruck, M.; Schindler, A.E. Thromboseprophylaxe in der Gynakologie: Doppleblind-Vergleich zwischen nierdermolekularem (LMWH) und unfraktioniertem (UFH) Heparin Geburtsch u Frauenheilk 1989 10.1055/s-2008-1036089 49 803
42. Sasahara, A.A.; Koppenhagen, K.; Haring, R.; Welzel, D.; Wolf, H. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis Br] Surg 1986 10.1002/bjs.1800730906 73 697
43. Voigt, J.; Hamelmann, H.; Hedderich, J.; Seifert, J.; Buchhammer, T.; Kohler, A. Wirksamkeit und unerwunschte wirkungen von neidermolekularem heparin-dihydroergotamin zur thromboembolieprophylaxe in der abdominalchirurgie Zentralbl Chir 1986 111 1296
44. Baumgartner, A.; Jacot, N.; Moser, G.; Krahenbuhl, B. Prevention of postoperative deep vein thrombosis by one dailv injection of low molecular heparin and dihydroergotamine U'asa 1989 18 152
45. Kakkar, VV, Stringer; MD, Hedges; AR, Parker; CJ, Welzer; D, Ward; V.P. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis Amj Surg 1989 10.1016/0002-9610(89)90589-8 157 413
46. Planes, A.; Vochelle, N.; Mazas, F.; Mansat, C.; Zucman, J.; Landais, A. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement Thromb Haemost 1988 10.1055/s-0038-1646980 60 407
47. MiN, Levine; J, Hirsh; Ml, Gent; AG, Turpie; J, Leclerc; PJ, Powers Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin Ann Intern Med 1991 114 454
48. Chiapuzzo, E.; Orengo, G.B.; Ottria, G.; Chiapuzzo, A.; Palazzini, E.; Fusillo, M. The use of low molecular weight heparins for post-surgical deep vein thrombosis prevention in orthopaedic patients 1988 10.1177/030006058801600505 Int Med Res 16 359
49. Pini, M.; Tagliaferri, A.; Manotti, C.; Lasagni, F.; Rinaldi, E.; Dettori, A.G. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures Int Angiol 1989 8 134
50. Haas, S.; Fritsche, H.M.; Ritter, H.; Stemberger, A.; Wendt, P.; Zeisel, H.J. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement Thromb Haemost 1985 54 319
51. Binsack, T.; Zellner, M.; Schimming, I.; Wirth, C.; Moser, E.; Riess, H. Thrombosis prophylaxis with LMW heparin and sodium heparin in patients with total hip replacement Thromb Res 1986 83
52. Barrej, Pfister G.; G, Potron; C, Droulle; JC, Baudrillard; Barbier Efficacite et tolerance comparee du Kabi 2165 et de l'eparine standard dans la prevention des thromboses veineuses profondes au cours des protheses totales de hanche.7 Mal Uasc 1987 12 90
53. Dechavanne, M.; Ville, D.; Berruyer, M.; Trepo, F.; Dalery, F.; Clermont, N. Randomized trial of low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deepvein thrombosis after elective hip surgery Haemostasis 1989 1 5
54. Eriksson, B.I.; Eriksson, E.; Wadenvik, H.; Tengborn, L.; Risberg, B. Comparison of low molecular weight heparin and unfractionated heparin in prophylaxis of deep vein thrombosis and pulmonary embolism in total hip replacement 7Thromb Haemost 1989 69 470
55. Monreal, M.; Lafoz, E.; Navarro, A.; Granero, X.; Caja, V.; Caceres, E. A prospective double-blind trial of a low molecular weight heparin once daily compared with a conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture J Trauma 1989 10.1097/00005373-198906000-00028 29 873
56. Leyvraz, P.; Bachmanb, F.; Hoek, J.; Buller, H.R.; Postel, M.; Samama, M. Prevention of deep vein thrombosis after hip replacement: randomized comparison between unfractionated heparin and low molecular weight heparin BAM 1991 10.1136/bmj.303.6802.543 303 543
57. Haas, S.; Stemberger, A.; Fritsche, H.M.; Welzel, D.; Wolf, H.; Lechner, F. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine Arzneimittelforschung 1987 37 839
58. Lassen, M.R.; Borris, L.C.; Christiansen, H.M.; Moller-Larsen, F.; Knudsen, V.E.; Boris, P. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low dose heparin and low molecular weight heparin in hip surgery BrJ Surg 1988 10.1002/bjs.1800750720 75 686
59. Lassen, M.R.; Borris, L.C.; Christiansen, H.M.; Moller-Larsen, F.; Knudsen, V.E.; Boris, P. Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine Arch Orthop Trauma Surg 1989 10.1007/BF00934150 108 10
60. Eriksson, B.I.; Zachrisson, B.E.; Teger-Nilsson, A.C.; Risberg, B. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement Brj Surg 1988 10.1002/bjs.1800751104 75 1053
61. Matzsch, T.; Bergqvist, D.; Fredin, H.; Hedner, U. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement Acta Chir Scand 1988 543 80
62. Matzsch, T.; Bergqvist, D.; Fredin, H.; Hedner, U.; Lindhagen, A.; Nistor, L. Comparison of the thromboprophylactic effect of a low molecular weight heparin versus dextran in total hip replacement Thrombosis and Haemorrhagic Disorders 1991 3 25
63. Hoffmann, R.; Largiader, F.; Roethlin, M. Perioperative Thromboembolieprophylaxe: niedrig dosiertes heparin oder low molecular weight heparinDHE, vorund nachteile. Eine prospektive, randomisierte untersuchung HelvChirActa 1987 54 521
64. Breyer, H.G.; Hahn, F.; Koppenhagen, K.; Bacher, P.; Werner, B. Prevention of deep vein thrombosis in orthopedic surgery: Fragmin versus heparinDHE Thromb Res 1987 23
65. Simes, R.J. Confronting publication bias: a cohort design for meta-analysis Stat Med 1987 10.1002/sim.4780060104 6 11
66. Simes, R.J. Publication bias: the case foran international registry oftrials JCtin Oncol 1986 4 1529
67. Dickersin, K. Report from the Panel on the Case for Registers of Clinical Trials at the eighth annual meeting of the Society of Clinical Trials Controlled Clin Trials 1988 10.1016/0197-2456(88)90010-4 9 76
68. Bergqvist, D. Postoperative thromboemnbolisn: frequency, etiology, prophylaxis 1983 129
69. Bergqvist, D. Postoperative thromboembolism: frequency, etiology, prophylaxis 1983 146
70. Colditz, G.A.; Tuden, R.L.; Oster, G. Rates of venous thrombosis after general surgery: combined results of randomized clinical trials Lancet 1986 10.1016/S0140-6736(86)91955-0 ii: 143
71. Leyvraz, P.F.; Richard, J.; Bachtnann, F.; Van Melle, G.; Treyvaud, J.M.; Livio, J.J. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement N Englj Med 1983 10.1056/NEJM198310203091605 309 954
72. Taberner, D.A.; Poller, L.; Thomson, J.M.; Lemon, G.; Weighill, F.J. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery BrJ Surg 1989 10.1002/bjs.1800760920 76 933